Hoth Therapeutics Announces $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, Dec. 29, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 2,000,000 shares of its common stock (or common stock equivalent in lieu thereof) and warrants to purchase up to an aggregate of 2,500,000 shares of common stock, at a purchase price of $5.00 per share and accompanying warrant in a private placement priced at-the-market under Nasdaq rules. The gross proceeds to the Company from the private placement are expected to be $10 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The private placement is expected to close on or about January 3, 2023, subject to the satisfaction of customary closing conditions.

Read more at prnewswire.com